The CDC and FDA can learn from Bangladesh about COVID-19

An article from Great Game India asked why COVID-19 has not yet killed everyone in Bangladesh. A poor, overcrowded, and medically underserved country. The news piece said,

Bangladesh just reported zero COVID deaths in the entire country in a 24-hour period. Charitably, one-quarter of the population is vaccinated. This poor, incredibly densely populated nation appears poised on the verge of achieving herd immunity – despite violating every principle the high priests of the pandemic assure us are necessary to beat COVID.

Compared to the US, UK, and Israel, Bangladesh has low levels of vaccination.

The graph below is from Our World in Data.

Share of the population that has received at least one dose of the COVID-19 vaccine

The report continues,

Bangladesh has a population of roughly 167 million people. These people are jammed together in an area the size of Pennsylvania. Pennsylvania has a population of roughly 13 million.

Bangladesh has a population density of over 3000 people per square mile. The population density of the United States is 94 people per square mile.

Dhaka, the nation’s capital, has a population density of 36,941 residents per square kilometer. That is 95,677 people per square mile.

Living conditions in Bangladesh are unsanitary, squalid, and dangerous. Bangladesh is a desperately poor country. Any academic talk of social distancing or disinfection of work areas or schools is an indulgence in fantasy.

People hang on by their fingernails. They survive. They have no time or money or resources for games. If anything we are being told by the lords of the lockdown is true, Bangladesh ought to be a killing field. This is the virus’s fantasy come true. The entire nation is a petri dish.

COVID should be tearing through the slums of Dhaka like wildfire, and the bodies should be stacked like cordwood in the narrow, filthy alleys that separate the shacks jammed with people and the gutters running with filth.

A single cough could infect dozens of people already weakened by other diseases, malnourished, and unable to afford medical care.

Comparing the number of COVID-19 cases to the UK, US, and Israel, we see the same pattern again.

It could be that testing is not done routinely. However, if someone gets hospitalized, most likely, they will get tested for COVID-19. Therefore if a COVID patient dies, that COVID death will be documented. Let’s look at the COVID deaths per million people.

The actual graph in our world in data is interactive. Daily new confirmed COVID-19 deaths in Bangladesh on November 27 is only 0.02 per million people. Not exactly zero, as Great Game India reported, but that is still low. Israel has 0.46, the UK has 1.8, and the US has 2.37.

The US has the FDA, CDC, and the National Institute of Health. Three health agencies that other countries look at to model their health policies.

Why is that? What’s the secret medicine in Bangladesh?

Could it be ivermectin?

Here is a Tweet,

In Bangladesh, as soon as people have fever, the doctors are prescribing Ivermectin. They are following a published protocol. People are buying and keeping them handy, in case.

— Asif Dowla (@audowla) February 3, 2021

Ivermectin recommended by Dr. Tarek Alam

The Daily Star reported in February 2021 that Dr. Tarek Alam announced that ivermectin could be used to treat and prevent COVID-19.

Long since Dr Tarek Alam, Head of Medicine Department of Bangladesh Medical College had announced that Ivermectin, an anti-parasitic drug can be repurposed for treatment and prevention of Covid-19 based on positive research findings by experts in Monash University, Australia, the drug has been widely prescribed by doctors across the nation. Research conducted by Dr Tarek Alam and Dr Rubaiul Murshed, chairperson of Shomman foundation, has been acknowledged not only in Bangladesh but all over the world.

People took Ivermectin on their own

Nasir et al. made a study on the people of Dhaka City, the capital of Bangladesh. It was published in August 2020. The study results showed, (My comment in italics in parentheses)

The prevalence of self-medication amid the outbreak of COVID-19 was 88.33% and only 179 (28.59%) took medication with doctors’ advice and remaining 447 (71.40%) respondents took the drugs as “self-medication” by other sources. The most frequently used anti-infective drugs during the outbreak were ivermectine (77.15%), azithromycin (54.15%), doxycycline (40.25%).

The common symptoms were fever, throat pain, dry-cough and a total of 105 (16.77%) respondents took medications without having any symptoms (they took it prophylactically).

Almost 355 (85.33%) had taken medication without doing any test for COVID-19.

Usually, I don’t agree with self-medicating without a doctor’s advice, but you cannot argue with success. If they followed the recommendations from the CDC and the FDA, they would have been dead! Sorry to say that, but that is true! Countries that followed the FDA, CDC, and Dr. Anthony Fauci have been duped big time!

A prospective study about ivermectin’s use in Bangladesh showed,

Results: In this study male and female were 64 and 36 respectively, the age ranged between 8 to 84 years. Retesting was done between 4 and 18 days of starting medication. All patients tested negative and their symptoms improved within 72 hours. There were no noticeable side effects.

Conclusion: Combination of Ivermectin and doxycycline was found to be very effective in viral clearance in mild and moderately sick COVID-19 patients.

Natural immunity from exposure to other people and ivermectin. Now we know why Bangladesh beat COVID-19.

Maybe the CDC, FDA, and Dr. Fauci can learn something from Bangladesh.

Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.

Don’t Get Sick!

If you find value in the articles, please consider a donation to show your support.

As an Amazon Associate, I earn from qualifying purchases.

Could it be ivermectin?

Ivermectin recommended by Dr. Tarek Alam

People took Ivermectin on their own

Share this:

Like this: